Atrial fibrillation (AFib) is a common and serious cardiovascular disease associated with significant morbidity and mortality. Given the incidence, prevalence, and life-threatening complications of AFib increase with age, Medicare is forced to absorb a majority of the substantial clinical and economic burden.